Wiens Gregory D, Pascho Ron, Winton James R
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon 97201, USA.
Appl Environ Microbiol. 2002 Aug;68(8):3969-77. doi: 10.1128/AEM.68.8.3969-3977.2002.
The gram-positive bacterium Renibacterium salmoninarum produces relatively large amounts of a 57-kDa protein (p57) implicated in the pathogenesis of salmonid bacterial kidney disease. Antigenic variation in p57 was identified by using monoclonal antibody 4C11, which exhibited severely decreased binding to R. salmoninarum strain 684 p57 and bound robustly to the p57 proteins of seven other R. salmoninarum strains. This difference in binding was not due to alterations in p57 synthesis, secretion, or bacterial cell association. The molecular basis of the 4C11 epitope loss was determined by amplifying and sequencing the two identical genes encoding p57, msa1 and msa2. The 5' and coding sequences of the 684 msa1 and msa2 genes were identical to those of the ATCC 33209 msa1 and msa2 genes except for a single C-to-A nucleotide mutation. This mutation was identified in both the msa1 and msa2 genes of strain 684 and resulted in an Ala(139)-to-Glu substitution in the amino-terminal region of p57. We examined whether this mutation in p57 altered salmonid leukocyte and rabbit erythrocyte binding activities. R. salmoninarum strain 684 extracellular protein exhibited a twofold increase in agglutinating activity for chinook salmon leukocytes and rabbit erythrocytes compared to the activity of the ATCC 33209 extracellular protein. A specific and quantitative p57 binding assay confirmed the increased binding activity of 684 p57. Monoclonal antibody 4C11 blocked the agglutinating activity of the ATCC 33209 extracellular protein but not the agglutinating activity of the 684 extracellular protein. These results indicate that the Ala139-to-Glu substitution altered immune recognition and was associated with enhanced biological activity of R. salmoninarum 684 p57.
革兰氏阳性菌鲑肾杆菌会产生相对大量的一种57千道尔顿的蛋白质(p57),该蛋白质与鲑科鱼类细菌性肾病的发病机制有关。通过使用单克隆抗体4C11鉴定出p57中的抗原变异,该抗体与鲑肾杆菌菌株684的p57结合力严重下降,但与其他七种鲑肾杆菌菌株的p57蛋白结合力很强。这种结合差异并非由于p57的合成、分泌或与细菌细胞的结合发生改变。通过扩增和测序编码p57的两个相同基因msa1和msa2,确定了4C11表位丢失的分子基础。684 msa1和msa2基因的5'端和编码序列与ATCC 33209 msa1和msa2基因的序列相同,只是有一个C到A的单核苷酸突变。该突变在菌株684的msa1和msa2基因中均被发现,并导致p57氨基末端区域的丙氨酸(139)到谷氨酸的替换。我们研究了p57中的这种突变是否改变了鲑科鱼类白细胞和兔红细胞的结合活性。与ATCC 33209细胞外蛋白的活性相比,鲑肾杆菌菌株684细胞外蛋白对奇努克鲑白细胞和兔红细胞的凝集活性增加了两倍。一项特异性定量p57结合试验证实了684 p57结合活性的增加。单克隆抗体4C11可阻断ATCC 33209细胞外蛋白的凝集活性,但不能阻断684细胞外蛋白的凝集活性。这些结果表明,丙氨酸139到谷氨酸的替换改变了免疫识别,并与鲑肾杆菌684 p57增强的生物学活性相关。